View drug registration information details.
| Items | Registration information |
|---|
| ID | 2046 |
|---|
| No | 2046 |
|---|
| Brand Name | CIPRO-A |
|---|
| Ingredients | CIPROFLOXACIN USP 250 MG/5 ML |
|---|
| Dosage Form | SUSPENSION |
|---|
| Primary Packaging | Bottle |
|---|
| Storage | |
|---|
| Shelf Life | 24 MONTHS |
|---|
| Pack Size | 60 ML /BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | RESPIRATORY TRACT INFECTIONS, SKIN AND SOFT TISSUE INFECTIONS, URINARY TRACT INFECTIONS, GONORRHEA AND OTHER SEXUALLY TRANSMITTED DISEASES, BACTERIAL, GASTROINTESTINAL INFECTIONS, BONE AND JOINT INFECTIONS, OSTEOMYELITIS, SURGICAL PROPHYLAXIS, OTHER INFEC |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE AND PINK COLORED PELLETS, WHICH FORM PINK COLORED SUSPENSION WITH CHARACTERISTICS ODOR AND TASTE |
|---|
| Note | |
|---|
| License Owner | PALAMY PHARMA CO., LTD |
|---|
| Manufacturer | THE ACME LABORATORIES LTD. |
|---|
| Country | BANGLADESH |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 I 4217/17 |
|---|
| FDD Registration Date | 19-MAY-2023 |
|---|
| Expiry Date | 18-MAY-2026 |
|---|
Back to drug list
|
